Catalyst Pharmaceuticals, Inc.
CPRXNASDAQHealthcare● Active
$31.29
+$0.02(+0.05%)
Market Cap$3.8B
P/E Ratio—
52W High$32.56
52W Low$19.05
Catalyst Pharmaceuticals, Inc.（CPRX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CPRX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.59B | $0.49B | $0.40B | $0.21B | $0.14B |
| Cost of Revenue | $0.09B | $0.07B | $0.05B | $0.03B | $0.02B |
| Gross Profit | $0.50B | $0.42B | $0.35B | $0.18B | $0.12B |
| Gross Margin %(computed) | 85.19% | 86.00% | 86.95% | 83.94% | 84.46% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.09B | $0.02B | $0.02B |
| G&A Expenses | $0.07B | $0.17B | $0.05B | $0.05B | $0.02B |
| Total Operating Expenses | $0.24B | $0.23B | $0.26B | $0.08B | $0.07B |
| Operating Income | $0.26B | $0.20B | $0.09B | $0.10B | $0.05B |
| Operating Margin %(computed) | 43.77% | 39.68% | 21.80% | 47.54% | 37.20% |
| Interest Income | $0.00B | $0.02B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.28B | $0.22B | $0.09B | $0.10B | $0.05B |
| Income Tax Expense | $0.07B | $0.05B | $0.02B | $0.02B | $0.01B |
| Net Income | $0.21B | $0.16B | $0.07B | $0.08B | $0.04B |
| Net Margin %(computed) | 36.39% | 33.33% | 17.93% | 38.79% | 28.03% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.75 | $1.38 | $0.67 | $0.80 | $0.38 |
| Wtd Avg Shares | 0.12B | 0.12B | 0.11B | 0.10B | 0.10B |
| EBITDA | $0.30B | $0.23B | $0.12B | $0.10B | $0.05B |
| EBITDA Margin %(computed) | 50.20% | 47.36% | 30.06% | 48.12% | 37.33% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Catalyst Pharmaceuticals, Inc.
关于Catalyst Pharmaceuticals, Inc.（CPRX）损益表
Catalyst Pharmaceuticals, Inc.（CPRX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CPRX实现营收$0.59B，毛利润$0.50B（毛利率85.19%），净利润$0.21B（净利率36.39%）。
常见问题
CPRX · 4 问Catalyst Pharmaceuticals, Inc.（CPRX）2025财年营收为$0.59B，同比up19.8%。
CPRX revenueCPRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08